Rice researchers engineer personalized treatments for movement impairments
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Jul-2025 17:11 ET (10-Jul-2025 21:11 GMT/UTC)
Miriam Merad, MD, PhD, an internationally acclaimed immunologist and oncologist, has been awarded the title of Chevalier de la Légion d'honneur [Knight of the Legion of Honor] by the French Republic. The prestigious distinction, presented at the Consulate General of France in New York by the Ambassador of France to the United States, honors Dr. Merad’s groundbreaking contributions to macrophage biology and immunology and her leadership in transforming the landscape of translational research and precision medicine. One of France’s highest civilian honors, the Legion of Honor recognizes individuals who have made extraordinary contributions to their fields and society at large. Dr. Merad was selected for her visionary research elucidating the role of innate immune cells in cancer and chronic inflammatory disease, as well as her commitment to fostering global scientific collaboration and advancing human health.
A new analysis of over 18,000 cancer cases shows that obese patients may respond better to immunotherapy treatments, but many questions remain.
Recent study indicates that VDAC2 can make liver cancer cells more susceptible to cell death.
Researchers at the University of Turku, Finland, have taken a step towards more personalized and effective cancer treatments. A new study has identified the conditions under which the antibody drug bexmarilimab can activate the body's own defense system against cancer, and how to identify patients who will benefit from the drug.
A new study published in Nature Cancer reveals that age-related metabolic decline impairs the efficacy of CAR-T cell therapy. Scientists at the University of Lausanne, Ludwig Institute for Cancer Research, Lausanne branch, demonstrate that declining NAD levels in aged T cells reduce their mitochondrial function and tumor-killing ability. Replenishing NAD reverses this dysfunction, suggesting a new strategy to enhance cell therapies for older cancer patients.